Tristel, the Suffolk based supplier of infection and contamination control products, announced in the July update that the final results to June 2011 are anticipated to show a pre-tax profit of at least £500,000 (vs. the expectation of at least £433,000 at April 2011).
After delays were announced in April, Tristel secured a marketing licence for the Stella system in China. VAH listing for the wipes system in Germany was approved in June and sales in Germany have increased throughout the final quarter of the financial year. Sales of the Crystel products into the pharmaceutical and personal care market have now begun.
The TSTL share price has decreased by 11% over the last year.
Tristel Plc is graded b by LCF Research. To learn more, follow the link.
